Erlanger has reached agreement to part ways with its former CEO and has named his replacement on Wednesday night.

Erlanger spokesperson Jennifer Tittsworth says former President and Chief Executive Officer Kevin M. Spiegel will receive a year's salary and cash equivalent for the cost of continuing health insurance benefits as part of the separation agreement that was reached with board of trustees.

Tittsworth says William L. Jackson Jr., MD, MBA, has been appointed as the health system’s new President and Chief Executive Officer.

“On behalf of Erlanger’s Board of Trustees, we welcome Dr. Jackson during this period of transition,” Griffin stated. “We have every confidence that he will continue Erlanger’s movement in a positive direction and strengthen relationships inside the health system and in the many communities we serve.”

Stay with the WRCB app for updates to this story.